TL;DR
Anthropic’s IPO materials say its roadshow is scheduled to begin Nov. 10, with the offering price expected Nov. 18 and Nasdaq trading under ticker ANT expected Nov. 19, subject to regulatory clearance. The materials report $17 billion in Q3 2026 revenue and a $23.3 billion net loss, including a $21.9 billion non-cash charge; the final offer price and share allocations are not yet known.
Anthropic has laid out a timetable for its planned initial public offering, saying its investor roadshow is due to start Nov. 10 and its shares are expected to begin trading on Nasdaq under the symbol ANT on Nov. 19. The dates depend on regulatory clearance, and the company says it expects to set the offering price on Nov. 18.
Get smart everyday buys delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The company’s IPO materials say it is offering Class A common stock to the public. Investors seeking shares can submit an indication of interest through a participating brokerage platform, but eligibility is determined by the individual platform. Anthropic says there is no guarantee that applicants will receive any shares, or all the shares they request. Allocations are expected to be communicated on the first day of trading.
Anthropic reported $17.0 billion in Q3 2026 revenue, alongside revenue growth of more than 12 times year over year, as detailed in its Claude business coverage. It also reported more than 11,900 customers generating at least $100,000 in trailing 12-month revenue, a customer count that grew more than 12 times year over year. The supplied IPO summary does not specify the exact comparison periods behind every growth metric beyond the stated year-over-year comparison.
The financial highlights list a $23.3 billion net loss and a negative 15% operating margin. Anthropic says the net loss includes a $21.9 billion non-cash charge tied to a change in the fair value of convertible notes, derivative liabilities and simple agreements for future equity, or SAFEs. It also reports a positive 15% adjusted operating margin. These measures use different definitions; the materials provided do not include enough detail to reconcile them or assess the company’s full financial position.
Anthropic’s IPO timeline and financial picture
Anthropic has outlined an expected Nasdaq debut under ticker ANT, subject to regulatory clearance. Its materials show rapid revenue growth alongside a substantial reported loss.
Expected IPO schedule
All dates are in Eastern time and depend on regulatory clearance.
Growth and reported results
The company’s figures pair fast expansion with losses; the supplied summary does not provide enough detail to reconcile the measures.
- Q3 2026 revenue grew more than 12 times year over year.
- Customers generating at least $100,000 in trailing 12-month revenue grew more than 12 times year over year.
- Reported net loss: $23.3 billion.
- Operating margin: negative 15%; adjusted operating margin: positive 15%.
- The reported loss includes a $21.9 billion non-cash charge.
Requesting shares
Investor access depends on brokerage eligibility and the allocation process.
Participating brokerage platforms determine who can submit an indication of interest.
Eligible investors can request shares through a participating platform.
Allocations are expected on the first trading day; applicants may receive fewer shares than requested or none.
What remains open
The supplied summary does not establish the full offer terms.
- Final offer price and price range
- Number of shares, offering size and expected valuation
- Share allocation terms and full financial disclosures
- Cash position, use of proceeds and other risks
What the IPO Puts in Focus
The offering would give public-market investors a way to buy shares in Anthropic, a major AI developer, and would put its financial performance under closer scrutiny. The figures released with the IPO materials present both rapid revenue growth and a large reported net loss. The stated non-cash valuation charge is a substantial component of that loss, but it does not eliminate the reported loss or by itself describe the company’s cash position.
The IPO could also broaden access to the company’s shares beyond private-market investors. However, a public listing would not mean every individual investor can obtain shares at the offering price: Anthropic says allocations are not guaranteed, while purchases after trading begins would be at the market price. That price can differ from the IPO price.
For readers evaluating the proposed offering, the headline growth figures are only part of the picture. The final price, number of shares offered, valuation and fuller details in regulatory filings will shape how investors can assess the company. The provided material does not state the offering size or a proposed price range.
Products Worth Considering
Dell UltraSharp U4025QW 40 5K2K WUHD Curved LED Monitor (21:9)
Apple iPad 11-inch (A16), 128GB, Wi-Fi, Silver
Apple MacBook Air 13.6-inch Laptop with M5 Chip, 16GB Memory, 512GB SSD, Midnight
As an affiliate, we earn on qualifying purchases.
IPO Schedule and Investor Access
Anthropic describes itself as a public benefit corporation focused on securing the benefits of AI and mitigating its risks. Its founders’ letter frames the technology as potentially consequential for scientific innovation, economic growth and medical research. Those statements describe the company’s stated mission and view of AI; they are not financial forecasts or evidence of IPO performance.
The company’s FAQ sets out the proposed sequence: the roadshow begins Nov. 10, the offering price is expected to be set Nov. 18, and public trading is expected to start Nov. 19, all dates in Eastern time and subject to regulatory clearance. Anthropic says the price will depend on clearance, investor demand and market conditions.
The materials also list an IPO fact sheet, financial statements, incorporation documents and a European prospectus. A prospectus is the regulatory document intended to provide detailed information about the offering and company. The supplied source excerpt lists these documents but does not reproduce their full contents, so it does not establish the full terms of the offer.
“The final IPO price is expected to be determined on November 18th (EST), based on regulatory clearance, investor demand and market conditions.”
— Anthropic IPO FAQ
Price, Valuation and Allocations
The final offer price and share allocation remain unknown. Anthropic says pricing is expected Nov. 18, but that date and the planned start of trading are contingent on regulatory clearance. The materials supplied do not give a price range, the number of shares being offered, the expected valuation or the amount Anthropic aims to raise.
It is also not clear from the provided summary how much of the offering, if any, consists of newly issued shares versus shares sold by existing holders. The excerpt lists financial statements and prospectus documents without providing their contents, so details about liquidity, the company’s cash position, use of proceeds and risks cannot be established here.
The Q3 2026 figures are presented as company financial highlights. The excerpt does not provide their accounting notes, full income statement or cash-flow data. Investors will need the complete regulatory disclosures to understand the assumptions and definitions behind the reported results, including the adjusted operating margin and the non-cash charge.
Roadshow and Pricing Milestones
Anthropic’s published schedule calls for the roadshow to begin Nov. 10. Subject to regulatory clearance, the company expects to set the IPO price on Nov. 18 and begin Nasdaq trading the following day under ticker ANT. These remain expected dates rather than guarantees.
People interested in requesting shares can check participating brokerage platforms for eligibility and submit an indication of interest where available. The company says the platforms will communicate allocations on the first trading day, and applicants should be prepared to purchase the shares they request even if they receive fewer than requested. The next key information for the market will be the final prospectus and pricing details, including the offer price and allocation terms.
Key Questions
When is Anthropic expected to go public?
Anthropic says trading is expected to begin on Nov. 19 on Nasdaq, subject to regulatory clearance. Its roadshow is scheduled to start Nov. 10.
What ticker symbol will Anthropic use?
The company’s IPO materials say its Class A common stock will trade on Nasdaq under the ticker ANT.
Has Anthropic set its IPO price?
No. The company says the price is expected to be set on Nov. 18, depending on regulatory clearance, investor demand and market conditions. The supplied materials do not state a price range.
Can investors request shares in the IPO?
Anthropic says investors can submit an indication of interest through a participating brokerage platform, if eligible. Share allocations are not guaranteed, and an applicant may receive fewer shares than requested or none.
What financial results did Anthropic disclose?
The IPO materials report $17.0 billion in Q3 2026 revenue and a $23.3 billion net loss. Anthropic says that loss includes a $21.9 billion non-cash charge related to fair-value changes in convertible notes, derivative liabilities and SAFEs. The excerpt does not provide the full financial statements.
Source: Hacker News
